Purchase Order 75F40123P00249
Award Date 7/27/23
Potential Completion Date 9/30/23
Potential Value $48K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Huntsville, AL 35806, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration (FDA) awarded a $91,630 firm-fixed-price purchase order contract to Discovery Life Sciences, LLC, a small disadvantaged business, for the delivery of 110 vials of primary cryopreserved human hepatocytes. This requirement supports the FDA's National Center of Toxicological Research (NCTR) Division of Biochemical Toxicology's research into drug toxicity and metabolic enzymes. The contract has a period of performance through August 19, 2024 and was awarded under a...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Discovery Life Sciences, LLC, a small disadvantaged business, on August 2, 2022. The contract has a ceiling value of $48,945.00 and a completion date of November 1, 2022. The contract is for the procurement of primary human hepatocytes and media, as requested in the FDA's Sources Sought Notice FDA-SSN-1252684. Discovery Life Sciences has over a decade of experience supporting federal agencies'...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. and headquartered in Grand Island, New York, has been awarded a $48.9K firm fixed-price purchase order by the Food and Drug Administration (FDA) for cryopreserved human hepatocytes, with a completion date of September 24, 2026. The contract, awarded on September 19, 2025, with no set-aside designation, will be performed at the vendor's location in Grand Island, NY. Life Technologies Corporation is a leading supplier...
- This is a fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of cryopreserved human hepatocytes, which are used to support biomedical research, medical readiness, and other federal initiatives. The contract has a ceiling value of $127,649.76 and a completion date of August 7, 2020. Life Technologies serves as a prime contractor...
- This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Life Technologies Corporation for the delivery of 50 vials of human spheroid-qualified hepatocytes. As described in the original solicitation, these liver cells will support the National Institute on Drug Abuse's Antiviral Program for Pandemics by enabling the continued identification of direct-acting antivirals and development of microphysiological systems...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,262.29 contract is for the delivery of primary human hepatocytes, which are a critical reagent used in biomedical research supported by NCATS. This contract is not associated with any set-aside...
- This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of advanced 3D cell culture technologies. The $46,829.63 contract tasks Insphero with providing 3D liver microtissues composed of human primary hepatocytes and other liver cells, which are used for drug-induced liver injury assays and toxicity testing. These...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of human induced pluripotent stem cell-derived cells. The $26,680 contract is to provide specialized cell cultures, including cardiomyocytes, neurons, astrocytes, and hepatocytes, to support the FDA's active research program. The award has no set-aside designation and is a sole-source award,...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $45,717 firm fixed price purchase order to Xenotech LLC, doing business as Sekisui-Xenotech, for the provision of cryopreserved human, mouse, and rat hepatocytes. The solicitation sought these hepatocytes for use in drug metabolism experiments to support the National Institute on Drug Abuse's malaria research project and understand drug metabolism in...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a firm fixed price purchase order to Life Technologies Corporation for the reinstallation of laboratory instruments at the agency's facility in Dauphin Island, Alabama. With a period of performance from June 18, 2017 through June 30, 2017, this $100,000 or less contract supports the FDA's mission to protect public health by ensuring the safety and effectiveness of medical devices through testing and...